Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IBIO
STRONG SELLiBio, Inc. · Healthcare · United States · $71M · Avg Vol: $1M/d
9
StockRankGet insider-trade alerts
Q
23
V
33
M
27
P/E (TTM)
—
ROE
-62.1%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)-14.2%
SMA 50SMA 200
Close
$1.45
RSI (14)
33.3
52W High
$3.82
From 52W High
0.4%
SCORE BREAKDOWN
Quality
23
ROIC
-160.8%3.4
ROE
-62.1%15.3
GP/Assets
1.3%13.7
Op. Margin
-9653.0%2.4
FCF/Assets
-95.6%1.8
Piotroski
239.0
Int. Cover
-50.0x6.3
D/E Ratio
0.03x75.6
Current Ratio
11.88x89.1
Value
33
P/E (TTM)
—N/A
EV/EBITDA
0.1x25.0
P/FCF
—N/A
P/B
0.6x93.9
P/S
236.8x5.2
Div Yield
—N/A
Momentum
27
52W High %
38%14.2
RS 6M
-43%18.7
SMA 50/200
0.90x41.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+45%51.9
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$71M
P/E (Forward)
-4.6x
Gross Margin
100.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IBIO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IBIO | iBio, Inc.(you) | $71M | 9 | STRONG SELL |
| ANVS | Annovis Bio, Inc. | $71M | 8 | STRONG SELL |
| GANX | Gain Therapeutics, Inc. | $75M | 8 | STRONG SELL |
| GOSS | Gossamer Bio, Inc. | $66M | 8 | STRONG SELL |
| HYFT | MindWalk Holdings Corp. | $64M | 8 | STRONG SELL |
| KALA | KALA BIO, Inc. | $63M | 9 | STRONG SELL |
| TELO | Telomir Pharmaceuticals, Inc. | $79M | 11 | STRONG SELL |
| HRTX | Heron Therapeutics, Inc. | $86M | 8 | STRONG SELL |
| MAIA | MAIA Biotechnology, Inc. | $75M | 12 | STRONG SELL |
| CGTX | Cognition Therapeutics, Inc. | $82M | 7 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%